These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36420189)

  • 21. Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity.
    Zhang A; Deek MP; Kim S; Sayan M; Grann A; Wagman RT; Malhotra U; Hathout L; Biswal N; Zhang Y; Langenfeld J; Kennedy T; August DA; Jabbour SK
    J Gastrointest Oncol; 2019 Jun; 10(3):513-522. PubMed ID: 31183202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
    Tang C; Lee MS; Gomez D; Levy LB; Zhuang Y; Lu C; Liao Z; Komaki R
    Am J Clin Oncol; 2017 Dec; 40(6):625-630. PubMed ID: 26165417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer.
    Colaco RJ; Nichols RC; Huh S; Getman N; Ho MW; Li Z; Morris CG; Mendenhall WM; Mendenhall NP; Hoppe BS
    J Gastrointest Oncol; 2014 Feb; 5(1):3-8. PubMed ID: 24490037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of chemotherapy on normal tissue complication probability models of acute hematologic toxicity in patients receiving pelvic intensity modulated radiation therapy.
    Bazan JG; Luxton G; Kozak MM; Anderson EM; Hancock SL; Kapp DS; Kidd EA; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):983-91. PubMed ID: 24161422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-volume effects for pelvic bone marrow in predicting hematological toxicity in prostate cancer radiotherapy with pelvic node irradiation.
    Sini C; Fiorino C; Perna L; Noris Chiorda B; Deantoni CL; Bianchi M; Sacco V; Briganti A; Montorsi F; Calandrino R; Di Muzio N; Cozzarini C
    Radiother Oncol; 2016 Jan; 118(1):79-84. PubMed ID: 26702990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation.
    David JM; Yue Y; Blas K; Hendifar A; Kabolizadeh P; Tuli R
    Adv Radiat Oncol; 2019; 4(4):613-622. PubMed ID: 31681863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma.
    Julie DA; Oh JH; Apte AP; Deasy JO; Tom A; Wu AJ; Goodman KA
    Acta Oncol; 2016; 55(2):208-16. PubMed ID: 25984929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting severe hematologic toxicity from extended-field chemoradiation of para-aortic nodal metastases from cervical cancer.
    Yan K; Ramirez E; Xie XJ; Gu X; Xi Y; Albuquerque K
    Pract Radiat Oncol; 2018; 8(1):13-19. PubMed ID: 28865761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc therapy.
    Xiang X; Ding Z; Zeng Q; Feng L; Qiu C; Chen D; Lu J; Li N
    Radiat Oncol; 2022 Mar; 17(1):48. PubMed ID: 35248087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy.
    Rahimy E; von Eyben R; Lewis J; Hristov D; Kidd E
    Strahlenther Onkol; 2022 Sep; 198(9):773-782. PubMed ID: 35059758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between Biological Effective Dose and Radiation-induced Liver Disease from Hypofractionated Radiotherapy.
    Bergamo AM; Kauweloa K; Gan G; Shi Z; Daniels J; Crownover R; Narayanasamy G; Stathakis S; Mavroidis P; Papanikolaou N; Gutierrez A
    J Med Phys; 2019; 44(3):185-190. PubMed ID: 31576066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation.
    Rose B; Mitra D; Hong TS; Jee KW; Niemierko A; Drapek LN; Blaszkowsky LS; Allen JN; Murphy JE; Clark JW; Ryan DP; Wo JY
    Pract Radiat Oncol; 2017; 7(5):e291-e297. PubMed ID: 28462895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy.
    Hui B; Zhang Y; Shi F; Wang J; Wang T; Wang J; Yuan W; Li Y; Liu Z
    Int J Gynecol Cancer; 2014 Nov; 24(9):1648-52. PubMed ID: 25275663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.
    Noticewala SS; Li N; Williamson CW; Hoh CK; Shen H; McHale MT; Saenz CC; Einck J; Plaxe S; Vaida F; Yashar CM; Mell LK
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):797-805. PubMed ID: 28244416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which Bone Marrow Sparing Strategy and Radiotherapy Technology Is Most Beneficial in Bone Marrow-Sparing Intensity Modulated Radiation Therapy for Patients With Cervical Cancer?
    Yu DY; Bai YL; Feng Y; Wang L; Yun WK; Li X; Song JY; Yang SS; Zhang YY
    Front Oncol; 2020; 10():554241. PubMed ID: 33392067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Chemotherapy Regimens on Normal Tissue Complication Probability Models of Acute Hematologic Toxicity in Rectal Cancer Patients Receiving Intensity Modulated Radiation Therapy With Concurrent Chemotherapy From a Prospective Phase III Clinical Trial.
    Cheng Y; Ma Y; Zheng J; Deng H; Wang X; Li Y; Pang X; Chen H; He F; Wang L; Wang J; Wan X
    Front Oncol; 2019; 9():244. PubMed ID: 31024846
    [No Abstract]   [Full Text] [Related]  

  • 37. Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.
    Barney CL; Scoville N; Allan E; Ayan A; DiCostanzo D; Haglund KE; Grecula J; Williams T; Xu-Welliver M; Otterson GA; Bazan JG
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):748-755. PubMed ID: 29413286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.
    Franco P; Arcadipane F; Ragona R; Lesca A; Gallio E; Mistrangelo M; Cassoni P; Arena V; Bustreo S; Faletti R; Rondi N; Morino M; Ricardi U
    Med Oncol; 2016 Jul; 33(7):72. PubMed ID: 27277756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
    Wan J; Liu K; Li K; Li G; Zhang Z
    Radiat Oncol; 2015 Aug; 10():162. PubMed ID: 26238572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematologic Toxicity and Bone Marrow-Sparing Strategies in Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review.
    Konnerth D; Gaasch A; Zinn A; Rogowski P; Rottler M; Walter F; Knoth J; Sturdza A; Oelmann J; Grawe F; Bodensohn R; Belka C; Corradini S
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.